A. William Blackstock

Author

Also Known As

A BLACKSTOCK, A Blackstock, A W Blackstock, A William Blackstock, A. Blackstock, A. W. Blackstock, A. William Blackstock, A.W Blackstock, A.W. Blackstock, A.William Blackstock

196

Publications

Citations

H-Index

Concepts

All Affiliations

Wake Forest University University of North Carolina at Chapel Hill Atrium Health Wake Forest Baptist Duke Medical Center SUNY Upstate Medical University

About

A. William Blackstock is an author at Wake Forest University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	34	1.1K
2	Health Sciences	16	22	679
3	Engineering	2	2	37
4	Cell Biology	2	2	70
5	Natural Sciences	1	1	20

A. William Blackstock

Publications

Citations

H-Index

Page 1

	Year	Citations
Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic Cancer A. William Blackstock, Stephen A. Bernard, Frederick Richards, Journal of Clinical Oncology	1999	239
Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105 Mark A. Socinski, A. William Blackstock, Jeffrey A. Bogart, Journal of Clinical Oncology	2008	177
Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer Edward A. Levine, Michael Farmer, Paige B. Clark, Annals of Surgery	2006	167
Outcomes of Patients With Esophageal Cancer Staged With [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection? Arta M. Monjazeb, Gregory Riedlinger, Mebea Aklilu, Journal of Clinical Oncology	2010	137
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis Julian C. Hong, D.N. Ayala-Peacock, Jason T. Lee, PLoS ONE	2018	128
The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy Brian E. Lally, Frank C. Detterbeck, Ann M. Geiger, Cancer	2007	107
Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B A. William Blackstock, James E. Herndon, Electra D. Paskett, JNCI Journal of the National Cancer Institute	2002	106
Cancer and Leukemia Group B (CALGB) 89805: Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas A. William Blackstock, Joel E. Tepper, Donna Niedwiecki, International Journal of Gastrointestinal Cancer Pancreatic CancerGastrointestinal OncologyMedicinePathologyLocoregional Adenocarcinoma	2003	103
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment Jeremy M. Kilburn, Jeffrey G. Kuremsky, A. William Blackstock, Radiotherapy and Oncology Radiation MedicineHealth SciencesRadiation TherapyMedicineSurgery	2014	85
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database Brian E. Lally, Ann M. Geiger, James J. Urbanic, Lung Cancer Cancer EpidemiologyMedicineCancer ManagementPathologyBronchial Neoplasm	2008	79

Page 1